These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26404233)

  • 1. Small-Molecule Inhibitors of the Type III Secretion System.
    Gu L; Zhou S; Zhu L; Liang C; Chen X
    Molecules; 2015 Sep; 20(9):17659-74. PubMed ID: 26404233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches targeting the type III secretion system to treat or prevent bacterial infections.
    Charro N; Mota LJ
    Expert Opin Drug Discov; 2015 Apr; 10(4):373-87. PubMed ID: 25727140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Noncompetitive Type Three Secretion System ATPase Inhibitors Shut Down
    Case HB; Mattock DS; Miller BR; Dickenson NE
    Biochemistry; 2020 Jul; 59(28):2667-2678. PubMed ID: 32567308
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Disk Diffusion Assay on Magnesium Oxalate Agar To Evaluate the Susceptibility of Yersinia pestis to Type III Secretion System Inhibitors.
    Prashar S; Portales Guemes M; Shivbaran P; Jimenez Alvarez E; Soha C; Nacer S; McDonough M; Plano GV; Torruellas Garcia J
    Microbiol Spectr; 2021 Sep; 9(1):e0000521. PubMed ID: 34132578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Type Three Secretion System in Pseudomonas aeruginosa.
    Anantharajah A; Mingeot-Leclercq MP; Van Bambeke F
    Trends Pharmacol Sci; 2016 Sep; 37(9):734-749. PubMed ID: 27344210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components.
    Hotinger JA; Pendergrass HA; May AE
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Targets of Type III Secretion System Inhibitors.
    Condry DL; Nilles ML
    Methods Mol Biol; 2017; 1531():203-211. PubMed ID: 27837494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.
    Lv C; Li Y; Wei Y; Wang J; Yu H; Gao F; Zhu C; Jia X; Tong M; Dong P; Gao Q; Geng L
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides.
    Fernandez-Brando RJ; Yamaguchi N; Tahoun A; McAteer SP; Gillespie T; Wang D; Argyle SA; Palermo MS; Gally DL
    Antimicrob Agents Chemother; 2016 Jan; 60(1):459-70. PubMed ID: 26525795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors.
    Case HB; Mattock DS; Dickenson NE
    Biochemistry; 2018 Dec; 57(50):6906-6916. PubMed ID: 30460850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.
    Lam H; Schwochert J; Lao Y; Lau T; Lloyd C; Luu J; Kooner O; Morgan J; Lokey S; Auerbuch V
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
    Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
    Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.
    Mühlen S; Zapol'skii VA; Bilitewski U; Dersch P
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0095821. PubMed ID: 34543097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.
    Cameron EA; Curtis MM; Kumar A; Dunny GM; Sperandio V
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton.
    Veenendaal AK; Sundin C; Blocker AJ
    J Bacteriol; 2009 Jan; 191(2):563-70. PubMed ID: 18996990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type III secretion system needle, tip, and translocon.
    Dey S; Chakravarty A; Guha Biswas P; De Guzman RN
    Protein Sci; 2019 Sep; 28(9):1582-1593. PubMed ID: 31301256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems.
    Blasey N; Rehrmann D; Riebisch AK; Mühlen S
    Front Cell Infect Microbiol; 2022; 12():1065561. PubMed ID: 36704108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Labeling Enzyme Tags for Analyses of Translocation of Type III Secretion System Effector Proteins.
    Göser V; Kommnick C; Liss V; Hensel M
    mBio; 2019 Jun; 10(3):. PubMed ID: 31239375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel
    Jiang S; He M; Xiang XW; Adnan M; Cui ZN
    J Agric Food Chem; 2019 Oct; 67(43):11867-11876. PubMed ID: 31584805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.